All In Biotech

Free tool

FAERS Monitor: Betamethasone Valerate

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018866 or its brand name (Betamethasone Valerate, Betamethasone Valerate). Reports on generic versions are filed under their own applications.

Reports

4,595

Serious

4,066

88% of reports

Hospitalization

1,341

Death reported

240

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,081
  • macular degeneration644
  • pain611
  • off label use501
  • pyrexia428
  • malaise424
  • nausea422
  • headache416
  • weight decreased416
  • pruritus353
  • rash338
  • abdominal pain308
  • erythema308
  • vomiting302
  • dyspnoea298

Reports by year received

View as table
YearReports
200413
200513
200615
200717
200821
200925
201039
201156
201252
201385
2014127
2015179
2016213
2017189
2018209
2019345
2020350
2021570
2022479
2023499
2024427
2025388
2026284

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,564 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
macular degenerationSignal644260.8242.2157,535
erythemaSignal3086.96.21,551
weight decreasedSignal4166.86.22,089
abdominal painSignal3086.15.41,311
pyrexiaSignal4285.75.21,666
painSignal6114.64.21,742
malaiseSignal4244.44.01,145
pruritusSignal3534.23.8875
drug ineffectiveSignal1,0813.83.62,328
rashSignal3383.63.2630
headacheSignal4163.02.8584
vomitingSignal3022.92.6394
off label useSignal5012.62.4522
nauseaSignal4222.42.2371
dyspnoeaSignal2982.42.2251

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.